1. Home
  2. NMRA vs BKTI Comparison

NMRA vs BKTI Comparison

Compare NMRA & BKTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • BKTI
  • Stock Information
  • Founded
  • NMRA 2019
  • BKTI 1997
  • Country
  • NMRA United States
  • BKTI United States
  • Employees
  • NMRA N/A
  • BKTI N/A
  • Industry
  • NMRA
  • BKTI Radio And Television Broadcasting And Communications Equipment
  • Sector
  • NMRA
  • BKTI Technology
  • Exchange
  • NMRA Nasdaq
  • BKTI Nasdaq
  • Market Cap
  • NMRA 268.5M
  • BKTI 247.9M
  • IPO Year
  • NMRA 2023
  • BKTI N/A
  • Fundamental
  • Price
  • NMRA $1.94
  • BKTI $78.83
  • Analyst Decision
  • NMRA Hold
  • BKTI Strong Buy
  • Analyst Count
  • NMRA 8
  • BKTI 1
  • Target Price
  • NMRA $5.83
  • BKTI $74.00
  • AVG Volume (30 Days)
  • NMRA 506.9K
  • BKTI 53.9K
  • Earning Date
  • NMRA 11-11-2025
  • BKTI 11-13-2025
  • Dividend Yield
  • NMRA N/A
  • BKTI N/A
  • EPS Growth
  • NMRA N/A
  • BKTI 292.72
  • EPS
  • NMRA N/A
  • BKTI 3.06
  • Revenue
  • NMRA N/A
  • BKTI $78,326,000.00
  • Revenue This Year
  • NMRA N/A
  • BKTI $11.20
  • Revenue Next Year
  • NMRA N/A
  • BKTI $10.66
  • P/E Ratio
  • NMRA N/A
  • BKTI $25.51
  • Revenue Growth
  • NMRA N/A
  • BKTI 4.63
  • 52 Week Low
  • NMRA $0.61
  • BKTI $23.58
  • 52 Week High
  • NMRA $17.19
  • BKTI $86.24
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 58.78
  • BKTI 62.43
  • Support Level
  • NMRA $1.70
  • BKTI $77.25
  • Resistance Level
  • NMRA $1.93
  • BKTI $82.29
  • Average True Range (ATR)
  • NMRA 0.13
  • BKTI 3.36
  • MACD
  • NMRA 0.01
  • BKTI -0.69
  • Stochastic Oscillator
  • NMRA 82.05
  • BKTI 49.44

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About BKTI BK Technologies Corporation

BK Technologies Corp a holding company, operates through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.

Share on Social Networks: